8-K ·Filed May 26, 2026

PGNY

Progyny, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed4mo ago SEC0001551306-26-000074
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

The buyback authorization provides downside support but is not a near-term catalyst given discretionary execution. Monitor actual repurchase activity in future filings for signal of management conviction. No earnings or guidance revision accompanies this filing.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
PGNY ▲ +1.92% at T+60d
NEUTRAL call ✓ call won +1.92% · α vs SPY -0.81% · entry $25.05 → $25.53
Entry anchored
May 26, 08:05 AM ET
via exchange tick
T+1d
+1.72%
call +1.72% · α +1.70%
$25.48
settled 4mo ago
T+5d
+4.59%
call +4.59% · α +3.51%
$26.20
settled 4mo ago
T+20d
+7.98%
call +7.98% · α +9.93%
$27.05
settled 3mo ago
T+60d
+1.92%
call +1.92% · α -0.81%
$25.53
settled 6w ago

Price Chart

Loading chart...

Executive Summary

Progyny announced a $200 million share repurchase program, funded from available cash. The program is discretionary with no obligation to repurchase any specific number of shares. This is a capital allocation signal but not a fundamental catalyst.

Key Facts

  • Board authorized up to $200 million in common stock repurchases
  • Program funded through available cash balances
  • Repurchases may be made via open market or Rule 10b5-1 plans
  • Program may be suspended or discontinued at any time
  • No assurances on number of shares or prices

Financial Impact

$200 million buyback authorization, representing approximately 10.5% of market cap at $1.9B

shares outstandingcash balance

Risk Factors

  • Buyback may not be executed if management deems conditions unfavorable
  • Cash used for repurchases reduces balance sheet flexibility
  • No fundamental improvement in business operations

Market Snapshot

Exchange
Nasdaq
Sector
Services-Misc Health & Allied Services, NEC
Analyst Consensus
82% bullish (17 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001551306-26-000074
Document: 0001551306-26-000074-index-headers.html0001551306-26-000074
Document: 0001551306-26-000074-index.html0001551306-26-000074
Document: 0001551306-26-000074.txt0001551306-26-000074
12 reports for PGNY
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for PGNY — sortable, filterable
TypeNow
Sep 10, 2026
22d ago
144
NEUTRAL ★ 2/10
$27.08 $27.01▼ −0.26%▲ +0.24%$25.23 (−6.83%)
Jul 23, 2026
10w ago
Press Release
NEUTRAL ★ 2/10
$30.70 $31.49▲ +2.57%▲ +2.10%$25.23 (−17.82%)
Jun 12, 2026
16w ago
Institutional Cluster
BEARISH ★ 5/10
$26.63 $26.08▲ +2.07%▲ +2.74%$25.23 (+5.26%)
Jun 3, 2026
17w ago
Insider Cluster
NEUTRAL ★ 3/10
$25.48 $25.65▲ +0.67%▲ +3.22%$25.23 (−0.98%)
Jun 3, 2026
17w ago
Insider Cluster
NEUTRAL ★ 3/10
$25.48 $25.65▲ +0.67%▲ +3.22%$25.23 (−0.98%)
May 28, 2026
18w ago
Press Release
BEARISH ★ 6/10
$25.69 $24.99▲ +2.72%▲ +2.68%$25.23 (+1.79%)
May 27, 2026
18w ago
144
NEUTRAL ★ 2/10
$25.48 $25.12▼ −1.41%▼ −2.62%$25.23 (−0.98%)
May 26, 2026
18w ago
8-K
NEUTRAL ★ 4/10
$25.05 $26.20▲ +4.59%▲ +3.51%$25.23 (+0.72%)
May 21, 2026
19w ago
Insider Cluster
NEUTRAL ★ 3/10
$24.88 $26.20▲ +5.31%▲ +3.63%$25.23 (+1.41%)
May 21, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.88 $26.20▲ +5.31%▲ +3.65%$25.23 (+1.41%)
Showing 10 of 12

US Market Status

Market Closed — Opens Mon (65h 25m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access